NeoGenomics Market Cap

NeoGenomics has a market cap or net worth of $1.53 billion as of January 2, 2026. Its market cap has decreased by -32.80% in one year.

Market Cap

1.53B

Enterprise Value

1.77B

1-Year Change

-32.80%

Ranking

#2214

Market Cap Chart

Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $1.53B, an increase of 19,259.04%. That is a compound annual growth rate of 27.31%.

Market Cap History

Date	Market Cap	% Change
Dec 31, 2025	1.52B	-28.07%
Dec 31, 2024	2.12B	2.57%
Dec 29, 2023	2.06B	76.73%
Dec 30, 2022	1.17B	-72.22%
Dec 31, 2021	4.20B	-29.72%
Dec 31, 2020	5.98B	95.74%
Dec 31, 2019	3.05B	160.37%
Dec 31, 2018	1.17B	64.64%
Dec 29, 2017	712.40M	5.87%
Dec 30, 2016	672.90M	41.66%
Dec 31, 2015	475.00M	89.92%
Dec 31, 2014	250.10M	41.06%
Dec 31, 2013	177.30M	57.88%
Dec 31, 2012	112.30M	85.62%
Dec 30, 2011	60.50M	24.49%
Dec 31, 2010	48.60M	-12.90%
Dec 31, 2009	55.80M	189.12%
Dec 31, 2008	19.30M	-43.07%
Dec 31, 2007	33.90M	-16.30%
Dec 29, 2006	40.50M	841.86%
Dec 30, 2005	4.30M	-20.37%
Dec 31, 2004	5.40M	-31.65%
Mar 16, 2004	7.90M	-

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	966.79B
Johnson & Johnson	498.51B
AbbVie	406.04B
UnitedHealth Group	300.88B
AstraZeneca	287.28B
Novartis AG	266.00B
Merck & Co.	263.24B
Novo Nordisk	227.63B

Market Cap Rankings